The bacterium Clostridioides difficile is named “difficult” for a reason. Originally it was hard to grow in the lab, and now ...

H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

Study finds underutilization of fidaxomicin, a recommended treatment for C. diff infection, despite increased use in hospitals.

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.

“I’ve spoken to too many Pennsylvanians who’ve lost loved ones to gun violence – that’s why today, my Administration took real action to re-establish and resource Pennsylvania’s Office ...

It is National Suicide Prevention Week, which is part of Suicide Prevention Month. Capitol High School's Hope Squad facilitated several events this week. That includes Chalk the Walk, which was a ...

There are about 500,000 cases of C. difficile each year; about one in six people with the infection will see it come back within two to eight weeks of the initial infection. “Treatment of C.

"You don't say you're going to take questions 1 through 15 if you're planning to be dead one hour later," said Mehta, 29, a mental health and suicide prevention advocate in Arlington, Virginia.

Objective: To describe emergent therapies, such as rifaximin, nitazoxanide, intravenous immunoglobulin (IVIG), tinidazole, tolevamer, and the possible use of a vaccine, in Clostridium difficile ...